Trump administration announces funding for PTSD research on ibogaineWIRED investigation examines Jensen Huang's comments on defining women's power in techWalmart launches early Black Friday promotions on select giftsMint Mobile offers $500 discount on select new phones for new customers signing up for a yearRussia and Iran criticize U.S. Caspian task force amid reports of joint sanction evasion effortsNewly elected US lawmakers pose for traditional group photo at Capitol ahead of 120th Congress openingUS existing home sales drop to lowest monthly level in yearsPro-Palestine philanthropist faces US extradition hearing in SpainLewisham Islamic Centre criticizes charity watchdog over warning on Palestine commentsSenegalese wrestlers succeed in beach wrestling at Dakar Youth OlympicsUS nonprofits file lawsuit seeking pause on advanced AI model trainingDemocrats convene in Denver to discuss party direction after midterm victoriesUS releases report on $12bn from Venezuelan oil, mineral resourcesPope Leo XIV urges Catholic Church to address clergy sexual abuseShooting near White House results in death, suspect later found dead
All fact checks
AI analysis

Fact check

“HHS recommended placing cannabis in Schedule III after reconsidering its potential for abuse.”
Mostly supportedConfidence: LOW

Reasoning

The claim that HHS recommended moving cannabis to Schedule III is corroborated by two secondary reporting articles, each quoting the recommendation. No evidence contradicts this statement.

On confidence: High confidence based on consistent reporting across independent secondary sources.

Important context

The recommendation pertains to the potential for abuse classification and was part of a broader discussion on drug scheduling; it does not indicate final regulatory action.

Evidence

Supporting (2)

Limitations

The evidence consists of secondary reporting articles rather than primary HHS documents, so the exact wording and scope of the recommendation cannot be confirmed directly from the source. No independent origin corroborated this claim, so it cannot be verified and confidence cannot be high.

Last verified:
Oct 2, 2026, 4:28 AM CDT
Pipeline:
2.1.0
Claim type:
Factual

Where this claim appeared

Hazy Drug Classification Criteria Invite Dubious Bureaucratic Judgments

Reason · Jacob Sullum